PanoramicaGraficoNotizieSchermataTrader

Soc. Generale Knock-Out GBF/  DE000SQ7L3C2  /

Frankfurt Zert./SG
31/05/2024  08:40:31 Var.+0.010 Denaro09:28:54 Lettera09:28:54 Sottostante Prezzo di esercizio Expiration date Tipo di opzione
2.060EUR +0.49% 2.010
Quantità in denaro: 4,000		 2.030
Quantità in lettera: 4,000		 BILFINGER SE O.N. 29.5706 EUR 31/12/2078 Call
GlobeNewswire 09:15 HSBC Continental Europe: Post Stabilisation Notice
Newsfile Corp 09:06 me88 Launches me scoreAI: Revolutionizing Football Predictions for UEFA Euro Cup 2024
Newsfile Corp 09:01 ReGen III Announces Closing of Initial Tranche of Convertible Debenture Offering
TeleTrader 09:00 Europe opens mixed ahead of CPI data
GlobeNewswire 09:00 insightsoftware to Strengthen xP&A and Write-Back Capabilities in Qlik With Fiplana Acquisition
TeleTrader 08:57 China says not providing arms to any side in Ukraine conflict
TeleTrader 08:48 French inflation unchanged at 2.2% in May
TeleTrader 08:44 NATO chief: Kremlin escalation threat not new
TeleTrader 08:30 Swiss retail sales up 2.7% in April
GlobeNewswire 08:14 STMicroelectronics to build the world’s first fully integrated silicon carbide facility in Italy
GlobeNewswire 08:09 DePIN Mining Aggregator ‘Hivello’ Launches Private Beta Application
TeleTrader 08:00 Annual UK house prices up 1.3% in May
TeleTrader 08:00 German retail sales down 0.6% in April
GlobeNewswire 08:00 Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares
TeleTrader 07:55 Europe higher premarket ahead of economic data
GlobeNewswire 07:54 Flash News: OKX Wallet Now Integrated with DIN
TeleTrader 07:50 OPEC+ reportedly seen extending cuts further
TeleTrader 07:41 Russian forces strengthen position in Donesk
GlobeNewswire 07:30 Baosheng Media Group Holdings Limited Announces Filing of Current Report on Form 6-K with the SEC re...
TeleTrader 07:19 Asia-Pacific mostly higher after China, Japan data
GlobeNewswire 07:05 Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
GlobeNewswire 07:05 Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
GlobeNewswire 07:00 Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type ...
GlobeNewswire 07:00 Press Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with typ...
GlobeNewswire 07:00 VEON discloses April YTD trading update at its AGM